A startup using regenerative medicine technologies to produce and supply homogeneous, high-precision blood cells at scale. It streamlines infectious disease research and the evaluation of pharmaceuticals and functional materials for efficacy and safety, while also providing research cells, testing cells, and diagnostic kits.
[画像: https://prtimes.jp/i/55964/3/resize/d55964-3-0c0cf85cdee7484e8db4-0.jpg ] ■受賞概要 当社は、再生医療技術を用いてヒトiPS細胞などから誘導した不死化ミエロイド系細胞（Mylc細胞：免疫細胞の一...
[画像: https://prtimes.jp/i/55964/2/resize/d55964-2-ff514c86260ac62f672a-0.jpg ] マイキャン・テクノロジーズ株式会社 (本社：京都府京都市、代表取締役：宮崎 和雄) は、国立研究開発法人 新エネルギー・...
[画像: https://prtimes.jp/i/55964/1/resize/d55964-1-65f8b292b1973b3cf657-0.png ] マイキャン・テクノロジーズ株式会社 (本社：京都府京都市、代表取締役：宮崎 和雄) は、リアルテックファンド3号投資事...
A startup aiming to save lives by merging emergency medical care with cutting-edge AI technology. We develop medical image diagnosis support AI and large-scale language models specialized for healthcare, challenging ourselves to reduce preventable deaths through the power of technology.
A startup engaged in the design, manufacturing, and sales of measurement devices using laser-plasma technology. It provides high-precision measurement and analysis solutions, enhancing efficiency and sophistication in research, development, and industrial applications.
A Deep Tech company combining AI with behavioral science to visualize and optimize human and organizational behavior. It supports sustainable behavior change that balances growth and well-being.
For the 1.2 million patients with chronic heart failure in Japan, a wristwatch-type wearable device will be used to detect heart murmurs and changes in activity levels specific to heart failure and recommend that patients seek medical attention. After the consultation, doctors will adjust oral medication, ultimately reducing re-hospitalization due to worsening heart failure.
